- Home
- ORIS vs XXII Comparison
ORIS vs XXII Comparison
Compare ORIS & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- XXII
- Stock Information
- Founded
- ORIS 2014
- XXII 1998
- Country
- ORIS China
- XXII United States
- Employees
- ORIS N/A
- XXII N/A
- Industry
- ORIS Farming/Seeds/Milling
- XXII Medicinal Chemicals and Botanical Products
- Sector
- ORIS Consumer Staples
- XXII Health Care
- Exchange
- ORIS Nasdaq
- XXII Nasdaq
- Market Cap
- ORIS 5.3M
- XXII 6.2M
- IPO Year
- ORIS 2024
- XXII N/A
- Fundamental
- Price
- ORIS $0.15
- XXII $1.62
- Analyst Decision
- ORIS
- XXII
- Analyst Count
- ORIS 0
- XXII 0
- Target Price
- ORIS N/A
- XXII N/A
- AVG Volume (30 Days)
- ORIS 45.4M
- XXII 3.6M
- Earning Date
- ORIS 01-01-0001
- XXII 11-11-2025
- Dividend Yield
- ORIS N/A
- XXII N/A
- EPS Growth
- ORIS N/A
- XXII N/A
- EPS
- ORIS 0.17
- XXII N/A
- Revenue
- ORIS $15,014,000.00
- XXII $21,362,000.00
- Revenue This Year
- ORIS N/A
- XXII N/A
- Revenue Next Year
- ORIS N/A
- XXII $126.57
- P/E Ratio
- ORIS $1.00
- XXII N/A
- Revenue Growth
- ORIS N/A
- XXII N/A
- 52 Week Low
- ORIS $0.08
- XXII $1.51
- 52 Week High
- ORIS $56.01
- XXII $617.90
- Technical
- Relative Strength Index (RSI)
- ORIS 45.57
- XXII 43.80
- Support Level
- ORIS $0.15
- XXII $1.59
- Resistance Level
- ORIS $0.19
- XXII $1.77
- Average True Range (ATR)
- ORIS 0.05
- XXII 0.15
- MACD
- ORIS -0.01
- XXII 0.03
- Stochastic Oscillator
- ORIS 5.47
- XXII 15.69
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.